<SEC-DOCUMENT>0001564590-21-013878.txt : 20210317
<SEC-HEADER>0001564590-21-013878.hdr.sgml : 20210317
<ACCEPTANCE-DATETIME>20210317163103
ACCESSION NUMBER:		0001564590-21-013878
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210316
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210317
DATE AS OF CHANGE:		20210317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptive Biotechnologies Corp
		CENTRAL INDEX KEY:			0001478320
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				270907024
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38957
		FILM NUMBER:		21750970

	BUSINESS ADDRESS:	
		STREET 1:		1551 EASTLAKE AVENUE EAST SUITE 200
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206-659-0067

	MAIL ADDRESS:	
		STREET 1:		1551 EASTLAKE AVENUE EAST SUITE 200
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptive TCR Corp
		DATE OF NAME CHANGE:	20091209
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>adpt-8k_20210316.htm
<DESCRIPTION>8-K FOR NEW DIRECTORS
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-17T14:26:43.5461606+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : e0724315b12040e9b0fb16cdb836d027 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:adpt="http://www.adaptivebiotech.com/20210316" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
adpt-8k_20210316.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001478320_20210316_20210316">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001478320_20210316_20210316">0001478320</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="adpt-20210316.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001478320_20210316_20210316">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001478320</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-16</xbrli:startDate>
					<xbrli:endDate>2021-03-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;border-top:Double 2.25pt;padding-top:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001478320_20210316_20210316">8-K</ix:nonNumeric><span style="font-size:6pt;font-weight:normal;">&#160;</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-left:40%;margin-right:40%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001478320_20210316_20210316" format="ixt:datemonthdayyearen">March 16, 2021</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001478320_20210316_20210316">ADAPTIVE BIOTECHNOLOGIES CORPORATION</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of Registrant as Specified in Its Charter) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:stateprovnameen">Washington</ix:nonNumeric></p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001478320_20210316_20210316">001-38957</ix:nonNumeric></p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001478320_20210316_20210316">27-0907024</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Incorporation)</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0001478320_20210316_20210316">1551 Eastlake Avenue East</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0001478320_20210316_20210316">Suite 200</ix:nonNumeric>,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0001478320_20210316_20210316">Seattle</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:stateprovnameen">Washington</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="margin-bottom:0pt;line-height:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0001478320_20210316_20210316">98102</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="margin-bottom:0pt;line-height:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0001478320_20210316_20210316">(206)</ix:nonNumeric> <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0001478320_20210316_20210316">659-0067</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Not Applicable </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former Name or Former Address, if Changed Since Last Report) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:39%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:20%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol(s)</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:39%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:39%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001478320_20210316_20210316">Common stock, par value $0.0001 per share</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:20%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0001478320_20210316_20210316">ADPT</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:39%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</p>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company &#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001478320_20210316_20210316" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-bottom:0pt;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 5.02</span></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-weight:normal;"></span>Departure of Directors or Certain Officers&#59; Election of Directors&#59; Appointment of Certain Officers&#59; Compensatory Arrangements of Certain Officers.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Departure of Directors</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 16, 2021, David Goel and Eric Dobmeier submitted their resignations to the Board of Directors (the &#8220;<span style="font-weight:bold;font-style:italic;">Board</span>&#8221;) of Adaptive Biotechnologies Corporation (the &#8220;<span style="font-weight:bold;font-style:italic;">Company</span>&#8221;), effective March 17, 2021.&#160;&#160;Messrs. Goel and Dobmeier each stated that they do not have any disagreement with the Company, its management, the Board or any committee of the Board on any matter.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Election of Directors</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 17, 2021, the Board, acting upon the recommendation of its Nominating and Corporate Governance Committee, appointed Leslie Trigg and Dr. Katey Einterz Owen as directors of the Company, to fill the vacancies created by the departures of Messrs. Goel and Dobmeier. Ms. Trigg will serve as a Class II director for a term expiring at the Company&#8217;s 2021 annual meeting of shareholders or upon her earlier death, resignation or removal. The Board also appointed Ms. Trigg to serve as a member of the Board&#8217;s Audit Committee.&#160;&#160;Dr. Owen will serve as a Class I director for a term expiring at the Company&#8217;s 2023 annual meeting of shareholders or upon her earlier death, resignation or removal. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Both Ms. Trigg and Dr. Owen will receive compensation for their service as members of the Board consistent with that received by the Company&#8217;s other non-employee directors pursuant to the Company&#8217;s Non-Employee Director Compensation Policy filed Exhibit 10.12 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board has affirmatively determined that each of Ms. Trigg and Dr. Owen are independent in accordance with applicable NASDAQ listing rules and have no material direct or indirect interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-top:0pt;text-align:justify;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Both Ms. Trigg and Dr. Owen will enter into the Company&#8217;s standard form of indemnification agreement with the Company, which will provide indemnification protection for each of them in connection with their service as a member of the Board.&#160;&#160;In addition, both Ms. Trigg and Dr. Owen will enter into the Company&#8217;s standard form of change in control agreement with the Company, which will provide for acceleration of all equity compensation awards under the 2019 Equity Incentive Plan in the event of a change of control.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item </span><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7.01</span></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Regulation FD Disclosure.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 17, 2021, the Company issued a press release announcing the foregoing appointments.&#160;&#160;The Company&#8217;s press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with General Instruction B.2 of Form 8-K, the information in the press release attached as Exhibit 99.1 hereto shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="font-weight:bold;font-style:italic;">Exchange Act</span>&#8221;), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01</span></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Financial Statements and Exhibits.</p></td></tr></table></div>
<p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"><span style="font-weight:normal;">(d) Exhibits.</span></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:15.84%; border-bottom:solid 0.75pt #000000;">
<p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No.</p></td>
<td valign="top" style="width:1.66%;">
<p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:82.44%; border-bottom:solid 0.75pt #000000;">
<p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description of Exhibits</p></td>
<td valign="top" style="width:0.06%;">
<p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="top" style="width:1.66%;">
<p style="margin-top:0pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&#160;</p></td>
<td valign="top" style="width:82.44%; border-top:solid 0.75pt #000000;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="adpt-ex991_24.htm"><span style="text-decoration:underline;">Press Release, dated March 17,2021</span></a><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="width:0.06%;">
<p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15.84%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="width:1.66%;">
<p style="margin-top:0pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&#160;</p></td>
<td valign="top" style="width:82.44%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></p></td>
<td valign="top" style="width:0.06%;">
<p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;">&#160;</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Adaptive Biotechnologies Corporation</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 17, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Chad Cohen</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chad Cohen</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>adpt-ex991_24.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
adpt-ex991_24.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g41htwh3dpjv000001.jpg" title="" alt="" style="width:186px;height:47px;"><font style="margin-left:36pt;"></font>EXHIBIT 99.1</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SEATTLE,&#160;March 17, 2021&#160;&#8211; Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced the appointments of Leslie Trigg and Katey Owen, Ph.D. to its Board of Directors effective immediately. The collective commercial and scientific expertise of these industry leaders will strengthen Adaptive&#8217;s ability to execute against its open-ended growth story. The company also announced that Eric Dobmeier and David Goel will retire from the Board after long-standing tenures.  </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;I am excited to welcome Leslie and Katey to our Board during this pivotal period of commercial expansion and scientific innovation. Diversity of thought, perspectives, and experience is essential as we seek to transform clinical care in many diagnostic and therapeutic areas,&#8221; said Chad Robins, chief executive officer of Adaptive Biotechnologies. &#8220;I&#8217;d like to thank Eric and David for the invaluable roles they played to help position Adaptive as a leader in immune medicine, as well as their guidance during the transition from a private to public company.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leslie&#8217;s expertise will be instrumental in the commercial adoption of Adaptive&#8217;s products into the clinical setting. She has served as Chief Executive Officer of Outset Medical since 2014, where she has pioneered disruptive technology transformation in the kidney dialysis space. With rapidly growing revenue across several market segments, Outset completed a successful public offering in 2020. Prior to Outset Medical, Leslie held executive commercial strategy roles at numerous med tech companies that went public or were acquired, including Pro-Duct Health, FoxHollow, AccessClosure, and Lutonix. She received her undergraduate degree from Northwestern University and her MBA from the Haas School of Business, UC Berkeley.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Katey&#8217;s expertise in developing late-stage biologics and vaccines at the Gates Foundation and Merck will help guide Adaptive&#8217;s expansion into new therapeutic areas. As Director at the Bill &amp; Melinda Gates Foundation, Dr. Owen has end-to-end responsibility for investments in diseases that impact a billion people on the planet. She also <font style="color:#000000;">facilitates regular interaction between Bill Gates and the CEOs of pharmaceutical organizations to achieve global health goals.&#160; </font>Prior to joining the pharmaceutical industry, she carried out academic research on influenza at the National Institute for Medical Research in Mill Hill, London. She earned her Ph.D. in molecular virology from Purdue University.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">About Adaptive&#160;Biotechnologies<font style="font-weight:normal;">&#160;</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;color:#000000;"><br /></font><font style="Background-color:#FFFFFF;font-weight:normal;">Adaptive Biotechnologies&#160;is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature&#8217;s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:50%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:9pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;font-weight:normal;">translates the massive genetics of the adaptive immune system with scale, </font><font style="Background-color:#FFFFFF;font-weight:normal;">precision</font><font style="Background-color:#FFFFFF;font-weight:normal;"> and speed to develop products in life sciences research, clinical diagnostics and drug discovery. We have three commercial products and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune </font><font style="Background-color:#FFFFFF;font-weight:normal;">conditions</font><font style="Background-color:#FFFFFF;font-weight:normal;"> and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. For more information, please visit </font><font style="text-decoration:underline;font-weight:normal;color:#000000;">adaptivebiotech.com</font><font style="font-weight:normal;color:#000000;">&#160;and follow us on&#160;</font><font style="text-decoration:underline;font-weight:normal;color:#000000;">www.twitter.com/adaptivebiotech</font><font style="text-decoration:underline;font-weight:normal;color:#000000;">.</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;color:#000000;">&#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Forward Looking Statements <font style="font-weight:normal;"><br />This press release contains forward-looking statements that are based on management's beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize and achieve market acceptance of our current and planned products and services, our research and development efforts and other matters regarding our business strategies, use of capital, results of operations and financial position and plans and objectives for future operations.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In some cases, you can identify forward-looking statements by the words "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors are described under "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the documents we file with the Securities and Exchange Commission from time to time. We caution you that forward-looking statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent our views as of the date hereof. We undertake no obligation to update any forward-looking statements for any reason, except as required by law.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ADAPTIVE MEDIA:<font style="font-weight:normal;"><br />Beth Keshishian<br />917-912-7195<br /></font><font style="text-decoration:underline;font-weight:normal;">media@adaptivebiotech.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ADAPTIVE INVESTORS:<font style="font-weight:normal;"><br />Karina Calzadilla<br />201-396-1687<br />Carrie Mendivil, Gilmartin Group<br /></font><font style="text-decoration:underline;font-weight:normal;">investors@adaptivebiotech.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g41htwh3dpjv000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g41htwh3dpjv000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "3 D8# 2(  A$! Q$!_\0
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M"S'\!DX]ZUJ^;O&UY->^,]5>=RQCN'B7V53M 'Y5OAZ*JRLR9RY4>P_\+/\
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M-I0E!W>42,^A8D?IBN?&TXI*2W+IM['24445YYJ%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !116)XNUH:#X8O;X,!*J;(?=VX'Y
M=?PIQ3D[(-CQ;XBZW_;7BZXV-FWM/]'CYX./O'_OK/Y"N3I2222223R2:2O<
MA%1BHHY6[NX44450CZ-\"ZW_ &[X3L[AWW7$0\F;UW+QD_48/XUT=>*_"+6_
MLFMSZ3*V([Q-T>?^>B_XC/Y"O:J\;$4^2HT=,'=!1116)04444 %%%137,%N
M,SSQQ#U=PO\ .@"6BJ::MILK;8]0M'/HLRG^M6PP89!!![BFTUN M?,_BO\
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M^[*.#^&/QK@O$<\5UXGU2X@D$D,MW*Z.O1E+$@UF45G&E&$N:(W)M685Z_\
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MKKOAMHR:QXO@\Y-T-JIN'4C@D$!1^9!_"N^<E&+DS)*[L=3X/^%D4UM'?^(
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MGV3/!M ^'^NZ](K"V:TM2>9[A2HQ[#JW\O>NU\2?"Z*'PS!'HB&6^MV+R,Y
M:<$#/L,8&!]>YKU*BL)8NHY)HM4U8^8'\/ZU&Y1](OU8=0;=_P#"MWP3I&IP
M>,]+EFTZ[CC6;+.\# #@]217T%15RQC::L)4TF%?,OBC_D;M9_Z_I_\ T,U]
M-5\R^*/^1NUG_K^G_P#0S3P/Q,578R:[?P9X*@\6:%J#"8P7D$JB*3JI!'1A
MZ>]<17L/P8_Y!>J?]=D_]!-=6(DXTVXD02;U/.M:\(:YH+M]ML9#$/\ EO$-
M\9'U'3\<5AU]85F77AS1;YBUUI-E*QZLT"D_GC-<T<;_ #(MTNQ\Q5+;6MQ>
M3+#;0232MT2-"Q/X"OHY?!GAI6!&B661ZQ UJVMC:6,?EVEK# G]V*,*/TJG
MCET0O9'D/A;X4W=U(EUKV;:W'/V93^\?ZD?='Z_2O8+6U@LK:.VMHDBAC7:B
M(, "IJ*XZM:51WD:QBEL%%%%9#"O-_&_PU&K3R:IHVR.\?YI8&.%E/J#V;]#
M[5Z115TZDJ;O$32:LSY:U#2[_2IS#?V<UO)G&)$(S]#T/X54KZLE@BN(S'-$
MDB'JKJ"#^!K(E\'^')FW/HECD^D*C^5=L<<OM(S=+L?-5>M_!V6^B2_MI;:<
M64F)8YF0A-_0@'H21C\J] M?#&A63A[?2+*-QT80+D?CBM0  8 Q6=;%*I'E
M2'&G9W/+?C!87E[+H_V2TGGV";=Y49;;G9C.*\R_L+5_^@5??^ [_P"%?4%%
M*GBG"*C8)4[NY\V:-HNJIKNGN^F7JJMS&2QMV  W#VKZ3'2BBLJU9U6FT5&/
M*%%%%8E"$!@01D'J*^=?$OA/4-,\17MK:Z?=2VRR%H7CA9AL/(&0.V<?A7T7
M16U&LZ3;1,H\Q\O_ -A:O_T"K[_P'?\ PH_L+5_^@5??^ [_ .%?4%%='UZ7
M8CV2/*_A+X;GM9KS5KZVDAD \B%94*GL6.#^ S]:]4HHKEJU'4ES,TBK*P44
M45F,0@$$$9!ZUYIXL^%<-]))>Z$R6\['<ULW$;'_ &3_  GVZ?2O3**NG4E3
M=XB:3W/E_4]#U31I3'J-C-;D' +K\I^C=#^!K/KZN=$D0HZ*RGJ&&0:R)_"?
MAZY;=+HMB6/4B!03^0KMCCOYD9NEV/FBIK:UN+R80VL$L\IZ)$A8G\!7T?'X
M.\-Q-N71+'/^U"I_G6K;VEM:1^7;6\4*?W8T"C]*;QRZ(7LCQ?P[\*-4U!TF
MU=OL-MU,8P96'TZ+^/Y5[!I.D6.B6"66GP+#"G8=6/J3W-7J*XZM:=3<TC%+
M8****R*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KYE\4?\C=K/_7]/_P"AFOIJOF7Q
M1_R-VL_]?T__ *&:[L#\3,JNQDU[#\&/^07JG_79/_037CU>Q_!E6&DZFV/E
M,Z@'W"__ %Q71B_X3(I_$>FT445Y)T!1110 4444 4(=:TZ?59M+BNXVOH5W
M20C.Y1Q_B/SJ_7D$FNV7AWXM:[?WS/Y8@VJJ+EG8B/ 'Y5O6OQ8TYKR.'4-.
MO+&.3[LL@R/J1UQ],UT2P\M'%7T)4UU.UU+5;#1[87&H74=M"6"AI#C)]*LQ
M2QSQ)+$ZO&ZAE93D,#T(KCOB,^BOX9M[C58KB>V-POE-:N V2I(.3P1@5LOJ
MFE>'/"]M=3.;>QB@18E/+$;1M4>IQ6?)[J:W8[ZFW17G ^+MGN$C:-?"S+8\
M_C^73]:Z2^\8Z?!X:CUNT26]MI'"!8!\P)SU!Z8Q3=&HMT"DF;EM>6M[&9+6
MYAG0'!:)PP!].*GKP_P!XRA\-:==P2:==W1EF#AH%! XQ@UZ?K/C'3-"T>VO
M[XR*UR@>*W49D;(!QCVSR:JI0E&7*M11DFKG0T5Y_!\5;)9XEU'2;^Q@E^Y/
M(N5^OT^F:[*]U>PT_2FU.YN42S"!_-SD,#TQCKGMBLY4YQ=FAIIEZH+V]M]/
MLY+N[E6*"(9=VZ 5P#?%VQW-)%H]^]HIP9L ?IT_6M#Q)KMAXA^&FJ7NGS>9
M$8PK C#(VY>".QJ_8S37,MQ<RZ'7V=Y;W]I'=6LJRP2C<CKT(J>O)M!^(]GH
MOABPL(=/NKV6WA_?M&,*G)/6N]\,^*=/\4V+7%D75XR%EBD&&0GI^!]:52C*
M%W;0%),W**\_;XLZ5Y<JQV%[)=+(8U@502^.^0>E:/AGX@Z=XBOVT]K>:SO0
M"5BEQ\V.H!]1Z$4.C42NT',CKZ*YWQ/XRTOPM&@NR\MS(,QP1 %B/4^@K!L?
MBMITEY'!J6GW>GK)]V6097ZGH0/?FE&C.2ND-R2T.SU/5[#1K9;C4;I+>%G"
M!WS@M@G'Z&K:.LD:NC!E89!'<5Y]\7F5_!]HR,&5KQ""#D$;'KJ9M:L= \,V
MU]J$WEPK"@&!DL=O  [FFZ?N)K=A?6QM45YP/B[9;A(^C7RV9; GX_ET_6NZ
MT[5K+5=-34+.=9+9USOZ8QUSZ$4ITIPUD@4D]B[17 7GQ5TY+Z2WTW3[O45C
M^]+$,+]1W(]^*M:;\2])U75+#3[6WNO.NCM;>H'E-SP>>>G:G["HE>PN9'3?
MVUIG]K?V5]MA^WE=WD;OFQC/\N<>E7ZX)H=!_P"%M*/LMU_:WE>9YF\>5]S&
M<=<[>/2M3Q+X[TSPY<K9-'-=WS8(MX!DC/3)[9].30Z;;2CU07[G4T5Q6C_$
MC3]0U---OK.ZTVZD($8N!@,3T&>Q/N*T/%'C.T\-2V]K]FFO+ZXYCMX1R1G&
M?SZ<&E[*?-RVU'S*US?N[N"QM9+JZE$4$8W.[= *SK/Q3H>H3)#:ZE#+)(VQ
M5!(R<9QS["LSPWXUA\0:A-IL^FW=C>QIO:*=.-OUP,=>XK/E\"7-QI.D63W<
M<+64L\K2Q$Y#,6*%>!G!(STZ52II:3T87OL=E;WUK=S7$5O.DCV[[)0I^XWH
M:*Q/"?AJ7PV+^-[@3K<2K(KDG<?EP2WN3D]Z*SDDGH,Z.BBBI **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *\JU;X2W>I:S?7RZK BW-Q),$,1)4,Q..OO7JM%:4ZLJ;O$3BG
MN>0Q?!BY\Q?-UF(1YYV0$G]37IFA:'9^'M*CT^R4B-.2S<L['J3[UI44ZE:=
M16DQ**6P4445D4%%%% !1110!Y38VUG=?'#4!>*C&-=\*MT,@1,?D-Q_"NM^
M(=K93^"=0>[5,Q)OB8]5?/&/KT_&L76/AM<ZIXHOM935?LS2X>W,2G=&X"@$
MGTX/3UJJ_P /O$FM3Q1^(?$7GV4;9V19);\P #[\UV-P<HRYMDC/6S5C$UF2
M:7X):*TQ)87>U2?[H,H'Z 5=\=[9KKP;:WKE=.D5/-.<#J@;\A_.NQ\5>$!K
M?ABUT6PECM([>1&3<I("JI&/UJQKGA*T\0>'H-,NW*R0(HBG0<HP&,X[@^E"
MK1NGYO\ $.5[&R]E9MI[6;P1?9/+V&(J-FWTQZ5YS\)SLG\0VT#L]A'.I@)/
M'5QG\0%_2@^!/&3VO]F/XH4Z;C9C+;MOIC'3VW8KM_#?ARS\,Z2MC:9;)W22
MM]Z1CW/^%9MQA!Q3O<K5M,XWX-_\@34O^OD?^@BLCQJU^_Q5LEM;6&[FCA0V
MT%P<1L<,>Y'?)Z]0*UC\/?$&EZC=GP[KJ6EE=-N9&R&4>@P#TSUX-;6O>!1K
MNEV EOWCU:RC5%OE7ER/49SUYZ\&M?:055SON39\MCG];C\?Z_I4VG7GAS3O
M*DQ\RRKN4CH03)P:Q?%5IJ.F^"?"^EZL&B59Y!.-P;: WR<@D?=)KI/^$.\;
M7:?9;WQ8%M<8)B!WD>_ )_.NHU#PI9ZKX8BT2]EEF6)%"7#$>8&48#?6DJL8
M-;6OTN'*V:UM:6D&GQVMO#&+41[510-NW'ZUR'B32M(TOX=ZRNCP01PR+EFB
M.=S;QU/MTQVK*3P)XPM[;^S;?Q2%T[&T?>#!?0>GTW5N0^ H+'P7>Z#9W),U
MV,R7$HZMD<X'0<=*S2C!I\U]2M6MB7X;VL$'@73VCC56F#O(0.6.XC)_  ?A
M7.^ H8[7XB>*+:!0D*,P5!T&)#C^==SX:TE]"\/6>F22K*]NI4NHP#EB?ZUE
M:#X4FTCQ7K&L274<D=^S%8U4@IEL\FCG7OZ[_P"8K/0YCX2VD+7FN7;1@S+,
ML:N1R%)8D#ZX'Y4[Q7!'!\6_#LT2A))MGF%>-WS$<_AQ72^#/"<_A?\ M'SK
MJ.?[7*'78I&W&?7ZTNM^%)M5\7Z3K274<<=CC=&RDEL,3P?QJW4C[5ROI;]!
M6?+8Y;38H+[XUZE_:0#20(3;(_3("[<#_=)/ZUTWQ&M;*?P5?27:INA4/"YZ
MJ^1C'UZ?C47BWP*NOWD6J6%XUAJD(&)ESA\=,XY!'J*Q3\/O$6M3PKXE\0B>
MSB;/E0DDM^8 !]\&A2A)QGS6L.S5U8P=>EFE^"^A-.27%UM&?[H\T+^@%7_'
M.R?5O!]I>L1ISJGF9.!R5#9_#'YUV'BSP?\ V]X<M=(L98K2.WE5DW*2 JJR
MX_6K&O\ A&T\1:!!IUTY26!1Y4Z#E& QT[@]Q35:-T_-_B)Q9LS65G)I[VDL
M$1M#'L:,J-FW'3'I7C&@S7$/@?QG#8N[6D;)Y+#NI8AC_P!\ 9KH6\">,IK7
M^S)O%"G3L;",L6*^F,<CVW8KL]&\-:9X?\/OIB*'MV5C</+_ ,M,CYBWMC]*
ME2C3C:][M#LY,S/AI;V47@FSDM53?+N:=AU+Y(.?IQ^%<UK<%E!\:-(-JJ++
M(%>X5/[_ ,W)]R,4ZP\%3 RW7A'Q=Y-A,=Q0,6V_7!Z_4 UC:/I,47Q3T^WL
MM0DU.2 &6\NF.07 ;///'*CJ>36D5'FE)/HQ.]DCHV_Y+HG_ %Z?^TS7,Z5/
MKX^(.O7&E:=:WNH)-(&%RP!C7>1\N6'L/I]:]&/A68_$%?$GVF/R1#Y?D[3N
M^[C.:H>(_ <M]K/]MZ'J+:=J1^^0#M<],\=..O4&IC5AL^U@<6<QXETGQUXH
MBMUN] LHI('W)+!,H<>V2YXZ'\*Z+Q1X5U;4;[3=<TJZCBUJSA56CD(PV,GC
MJ.K,.>#FHH/!GBJ]NX9-:\4N8H9%D$=L"-Q!R.P'Y@U?\2>$-3O=:76M#UF2
MROA&(V20DHP'YX'M@CO1[17236E^CL%BOX7\87=SX@;0]?TU+/5MGRR(.)
M3COVR1@D=>E=U7$^&_!5]9Z^VOZ]J0OM1VE4V#"ID8SV[9&,#J:[:L*O+S>Z
M7&]M0HHHK(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1SP
MQW-O)!,BR12*4=&&0P/!!HHH ^=_&NF6>D^(YK6QA\F$'A Q/\S7KOP]TBPL
M/#T-U;6R1SW"YEDR2S8]SV]J**[\1)^QB907O,Z^BBBN U"BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>adpt-20210316.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-17T04:19:30.2336348+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : e0724315b12040e9b0fb16cdb836d027 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:adpt="http://www.adaptivebiotech.com/20210316" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.adaptivebiotech.com/20210316" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.adaptivebiotech.com/20210316/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adpt-20210316_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adpt-20210316_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>adpt-20210316_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-17T04:19:30.2336348+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : e0724315b12040e9b0fb16cdb836d027 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>adpt-20210316_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-17T04:19:30.2336348+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : e0724315b12040e9b0fb16cdb836d027 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20210316/role/TemplateLink" xlink:href="adpt-20210316.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="adpt-20210316.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>adpt-8k_20210316_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adpt-20210316.xsd" xlink:type="simple"/>
    <context id="C_0001478320_20210316_20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001478320</identifier>
        </entity>
        <period>
            <startDate>2021-03-16</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001478320_20210316_20210316" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001478320_20210316_20210316" id="F_000004">0001478320</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001478320_20210316_20210316" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001478320_20210316_20210316" id="F_000002">2021-03-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001478320_20210316_20210316" id="F_000003">ADAPTIVE BIOTECHNOLOGIES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001478320_20210316_20210316" id="F_000007">WA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001478320_20210316_20210316" id="F_000006">001-38957</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001478320_20210316_20210316" id="F_000008">27-0907024</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001478320_20210316_20210316" id="F_000009">1551 Eastlake Avenue East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001478320_20210316_20210316" id="F_000010">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001478320_20210316_20210316" id="F_000011">Seattle</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001478320_20210316_20210316" id="F_000012">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001478320_20210316_20210316" id="F_000013">98102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001478320_20210316_20210316" id="F_000014">(206)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001478320_20210316_20210316" id="F_000015">659-0067</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001478320_20210316_20210316" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001478320_20210316_20210316" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001478320_20210316_20210316" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001478320_20210316_20210316" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001478320_20210316_20210316" id="F_000020">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001478320_20210316_20210316" id="F_000021">ADPT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001478320_20210316_20210316" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001478320_20210316_20210316" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140053614209192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 16, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 16,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ADAPTIVE BIOTECHNOLOGIES CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001478320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-0907024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1551 Eastlake Avenue East<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Seattle<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(206)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">659-0067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADPT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M4M9'7\.1XRY88"15SJ=X?CZXC$S>P@U+U_SDOKQ!Z-&?W_E_U#$Y1T=:^WD
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M6]5C6)>E:H\_A?<HN9\;[O\2Q0]02P,$%     @ X(-Q4I>*NQS     $P(
M  L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2
M!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4
M+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(
M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/I
MKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #@@W%2'#AE
MZC\!   \ @  #P   'AL+W=O<FMB;V]K+GAM;(U1RV["0 S\E=5^0!-0BU1$
MN)0^D*H6E8K[DG6(Q3XBKP,M7U\G452D7GKR>FR-9V87YTC'?8Q']>5=2(6N
MF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,9
M2L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3 QFU+
MBLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)
M'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND
M53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R
M( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ X(-Q
M4B0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61
M/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?
M:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-D
MGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R
M&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    (
M ."#<5)ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#
M,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7
MK-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ
M*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@
M9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WC
MEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2F
MKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_F
MB^$_7G\!4$L! A0#%     @ X(-Q4@=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #@@W%22AFA/.\
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ."#<5*7BKL<P    !,"   +
M      "  :L.  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ."#<5(<.&7J/P$
M #P"   /              "  90/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " #@@W%2)!Z;HJT   #X 0  &@              @ $ $0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #@@W%299!YDAD!  #/
M P  $P              @ 'E$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"   O$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="adpt-8k_20210316.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="adpt-8k_20210316.htm">adpt-8k_20210316.htm</File>
    <File>adpt-20210316.xsd</File>
    <File>adpt-20210316_lab.xml</File>
    <File>adpt-20210316_pre.xml</File>
    <File>adpt-ex991_24.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "adpt-8k_20210316.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "adpt-8k_20210316.htm"
     ]
    },
    "labelLink": {
     "local": [
      "adpt-20210316_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adpt-20210316_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "adpt-20210316.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "adpt",
   "nsuri": "http://www.adaptivebiotech.com/20210316",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "adpt-8k_20210316.htm",
      "contextRef": "C_0001478320_20210316_20210316",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "adpt-8k_20210316.htm",
      "contextRef": "C_0001478320_20210316_20210316",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "verboseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.adaptivebiotech.com/20210316/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-21-013878-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-013878-xbrl.zip
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M3T"5F"\TM>(C4U,=4L_M^U4;.F7\;"/PW#.TM:O=P',2 YNG4/WI.>),0+J
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MKBA8->1KP,#L\1W20#/X*N@.F;HO>M0=8HJ;@W:-BZ:2 .D0;?&"^8/6SN<
MS*-9WCK"]^B 6&F6SQ)I$=%,YE)U&#&OZL0\4Z95+?HV!OFL/X[A!U[01S>H
M/KW=X9E#1S;]W.#'A/5Z3'U@)09?68,OLN[TO]^9$,#14UA.P*A"Q^H() *2
M2H3;F#B!,F$'%+I%<]1Q!>USIK?3E9&*:ZE/;&20($ 35$N3XR3L=:XP[L C
MLEALAT:EOBH%MP.,DO6<OM?FB9W(CE1Y_SI6[?L3*^58K$SH[QB\*>5)C4*
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M_HO!_P!02P$"% ,4    " #@@W%2C"+=!K0$  #9%@  $0
M@ $     861P="TR,#(Q,#,Q-BYX<V102P$"% ,4    " #@@W%2%H"H##4'
M  "'3   %0              @ 'C!   861P="TR,#(Q,#,Q-E]L86(N>&UL
M4$L! A0#%     @ X(-Q4M=0UCL6!0  OBT  !4              ( !2PP
M &%D<'0M,C R,3 S,39?<')E+GAM;%!+ 0(4 Q0    ( ."#<5)U7-N)214
M /BQ   4              "  901  !A9'!T+3AK7S(P,C$P,S$V+FAT;5!+
M 0(4 Q0    ( ."#<5*#SZ._"@X  -,P   1              "  0\G  !A
F9'!T+65X.3DQ7S(T+FAT;5!+!08     !0 % $8!  !(-0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
